Literature DB >> 24556606

Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Jinke Xu1, Wei Lu2, Senlin Zhang3, Chuchao Zhu4, Tingting Ren4, Tong Zhu4, Hu Zhao4, Yanpu Liu5, Jin Su4.   

Abstract

Background Discoidin domain receptor 2 (DDR2) is a unique receptor tyrosine kinase (RTK) that is activated by fibrillar collagens. Although DDR2 contributes to the metastasis of some tumors, its role in head and neck squamous cell carcinoma (HNSCC) remains unknown. The aim of this study was to investigate the expression level, clinical and pathological significance, and biologic function of DDR2 in HNSCC. Methods Real-time quantitative PCR, western blot, and immunohistochemical staining were employed to assess the expression levels of DDR2 in HNSCC specimens. Adenovirus-mediated overexpression of DDR2 was used to evaluate its consequences on cell proliferation, invasion, migration, and the process of hypoxia-induced epithelial-mesenchymal transition (EMT). Then nude mouse xenograft and tail vein metastasis models were utilized to validate the in vitro results. Results DDR2 was highly expressed in high grade HNSCC tissues and lowly expressed in low grade HNSCC tissues, but absent or rarely expressed in cancer-associated normal tissues. Both the frequency and expression intensity of DDR2 were significantly associated with tumor pathologic stage and lymph node metastasis. In vitro, DDR2 overexpression in HNSCC cells failed to alter cell proliferation but markedly accelerates cell invasion and migration as well as hypoxia-induced EMT. In vivo, elevated expression of DDR2 speeds up the metastasis of HNSCC cells to the lung. Conclusion DDR2 plays an important role in HNSCC metastasis, and might be a promising target for future therapies in this type of cancer.

Entities:  

Keywords:  DDR2; EMT; HNSCC; hypoxia; tumor metastasis

Mesh:

Substances:

Year:  2014        PMID: 24556606      PMCID: PMC4026084          DOI: 10.4161/cbt.28181

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  31 in total

Review 1.  Molecular mediators of metastasis in head and neck squamous cell carcinoma.

Authors:  Gina M S Howell; Jennifer R Grandis
Journal:  Head Neck       Date:  2005-08       Impact factor: 3.147

2.  Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2.

Authors:  Elvira Olaso; Juan-Pablo Labrador; LiHsien Wang; Kazuo Ikeda; Francis J Eng; Rudiger Klein; David H Lovett; Hsin Chieh Lin; Scott L Friedman
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

3.  The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism.

Authors:  J P Labrador; V Azcoitia; J Tuckermann; C Lin; E Olaso; S Mañes; K Brückner; J L Goergen; G Lemke; G Yancopoulos; P Angel; C Martínez; R Klein
Journal:  EMBO Rep       Date:  2001-05       Impact factor: 8.807

4.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.

Authors:  E Olaso; K Ikeda; F J Eng; L Xu; L H Wang; H C Lin; S L Friedman
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.

Authors:  S Kurahara; M Shinohara; T Ikebe; S Nakamura; M Beppu; A Hiraki; H Takeuchi; K Shirasuna
Journal:  Head Neck       Date:  1999-10       Impact factor: 3.147

6.  Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.

Authors:  Ryo Kawata; Taketoshi Shimada; Susumu Maruyama; Yasuo Hisa; Hiroshi Takenaka; Yasushi Murakami
Journal:  Acta Otolaryngol       Date:  2002-01       Impact factor: 1.494

Review 7.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

8.  Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor.

Authors:  C R Leemans; R Tiwari; J J Nauta; I van der Waal; G B Snow
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

9.  Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells.

Authors:  Takashi Masui; Ichiro Ota; Jong-In Yook; Shinji Mikami; Katsunari Yane; Toshiaki Yamanaka; Hiroshi Hosoi
Journal:  Int J Oncol       Date:  2013-12-23       Impact factor: 5.650

10.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

View more
  13 in total

1.  Prognostic significance of discoidin domain receptor 2 (DDR2) expression in ovarian cancer.

Authors:  Yi Fan; Zhe Xu; Jin Fan; Liu Huang; Ming Ye; Kun Shi; Zheng Huang; Yaqiong Liu; Langchi He; Jiezhen Huang; Yibin Wang; Qiufeng Li
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 2.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

3.  DDR2 facilitates papillary thyroid carcinoma epithelial mesenchymal transition by activating ERK2/Snail1 pathway.

Authors:  Zhong Liang; Wen-Jun Xie; Ming Zhao; Guo-Ping Cheng; Mei-Juan Wu
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

4.  Primary and Metastatic Melanoma With NTRK Fusions.

Authors:  Cecilia Lezcano; Alexander N Shoushtari; Charlotte Ariyan; Travis J Hollmann; Klaus J Busam
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

5.  Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.

Authors:  Joshua D Smith; Andrew C Birkeland; Andrew J Rosko; Rebecca C Hoesli; Susan K Foltin; Paul Swiecicki; Michelle Mierzwa; Steven B Chinn; Andrew G Shuman; Kelly M Malloy; Keith A Casper; Scott A McLean; Gregory T Wolf; Carol R Bradford; Mark E Prince; John Chad Brenner; Matthew E Spector
Journal:  Head Neck       Date:  2018-12-12       Impact factor: 3.147

Review 6.  Complex roles of discoidin domain receptor tyrosine kinases in cancer.

Authors:  V Mehta; H Chander; A Munshi
Journal:  Clin Transl Oncol       Date:  2021-02-25       Impact factor: 3.405

Review 7.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

8.  Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

Authors:  Matthew L Hedberg; Gerald Goh; Simion I Chiosea; Julie E Bauman; Maria L Freilino; Yan Zeng; Lin Wang; Brenda B Diergaarde; William E Gooding; Vivian W Y Lui; Roy S Herbst; Richard P Lifton; Jennifer R Grandis
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

9.  DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.

Authors:  Binhui Xie; Weihao Lin; Junming Ye; Xiaonong Wang; Bing Zhang; Shiqiu Xiong; Heping Li; Guosheng Tan
Journal:  J Exp Clin Cancer Res       Date:  2015-09-11

10.  TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.

Authors:  Whitney R Grither; Laura M Divine; Eric H Meller; Daniel J Wilke; Riva A Desai; Andrew J Loza; Peinan Zhao; Anne Lohrey; Gregory D Longmore; Katherine C Fuh
Journal:  Oncogene       Date:  2018-01-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.